PubMed=8590302; DOI=10.1089/jir.1995.15.1005
Oka M., Hirose K., Iizuka N., Aoyagi K., Yamamoto K., Abe T., Hazama S., Suzuki T.
Cytokine mRNA expression patterns in human esophageal cancer cell lines.
J. Interferon Cytokine Res. 15:1005-1009(1995)

PubMed=8974001; DOI=10.1089/jir.1996.16.1001
Oka M., Iizuka N., Yamamoto K., Gondo T., Abe T., Hazama S., Akitomi Y., Koishihara Y., Ohsugi Y., Ooba Y., Ishihara T., Suzuki T.
The influence of interleukin-6 on the growth of human esophageal cancer cell lines.
J. Interferon Cytokine Res. 16:1001-1006(1996)

PubMed=10778992
Yang H.-L., Dong Y.-B., Elliott M.J., Liu T.-J., McMasters K.M.
Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells.
Clin. Cancer Res. 6:1579-1589(2000)

PubMed=11115554; DOI=10.3892/ijo.18.1.157
Fujii T., Kato S., Yamana H., Tanaka Y., Fujita H., Shirouzu K., Morimatsu M.
Expression of G1 cell cycle markers and the effect of adenovirus-mediated overexpression of p21Waf-1 in squamous cell carcinoma of the esophagus.
Int. J. Oncol. 18:157-163(2001)

PubMed=18575732; DOI=10.3892/or.20.1.155
Kawaoka T., Oka M., Takashima M., Ueno T., Yamamoto K., Yahara N., Yoshino S., Hazama S.
Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.
Oncol. Rep. 20:155-163(2008)

PubMed=20515944; DOI=10.1158/1535-7163.MCT-09-0918; PMCID=PMC2884061
Seki N., Toh U., Sayers T.J., Fujii T., Miyagi M., Akagi Y., Kusukawa J., Kage M., Shirouzu K., Yamana H.
Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways.
Mol. Cancer Ther. 9:1842-1851(2010)

PubMed=26317542; DOI=10.18632/oncotarget.4540; PMCID=PMC4694873
Chen Q.-R., Song S.-M., Wei S.-Z., Liu B., Honjo S., Scott A., Jin J.-K., Ma L., Zhu H.-T., Skinner H.D., Johnson R.L., Ajani J.A.
ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer.
Oncotarget 6:25883-25896(2015)